Realize the Potential of Genomic Data in Drug Development

Ovation offers a consented biobank of ~1.6 million samples that can be sequenced to generate genomic data across more than 60 pre-defined disease cohorts

Inflammatory Bowel Disease Omic Data

Consented samples (Sample types include FFPE tissue, nasopharyngeal swabs, preserved saliva, whole blood, total nucleic, and more)

Unique Patients

Tissue Samples

New Samples per Month

Pre-defined disease cohorts

Samples are sequenced to deliver:

  • Whole genome sequencing (30X Depth)
  • Whole exome sequencing
  • mRNA and RNA sequencing
  • And more

Cohorts are developed through linkage to phenotypic data using common tokens.

Phenotypic and clinical data including treatment exposure, comorbidities, lab value and disease severity metrics from top claims and/or EHR vendors is linked to genomic data from Ovation’s database.

Let’s work together to advance
science forward

Our team combines the best of the tech and biotech worlds with vast experience managing large clinical and genomic data sets. Our delivery teams and clinical affairs specialists work together to deliver the highest quality data.

Explore more about
Ovation’s Data Products


Resources_Datavant Webinar

Linking Genomic and Phenotypic Data to Understand the Patient Journey

Data in Action


Realizing the Value of Biospecimens for Life Sciences Research in IBD

Thought Leadership


Ovation Presents at the 2023 AWS Life Sciences Executive Symposium

Linking Genomic and Phenotypic Data to Better Understand the Patient Journey

In partnership with Datavant, we explore how researchers can overcome the challenges posed by..

Case Study: Realizing the value of biospecimens for life sciences research in IBD

Author Ovation Team View all..

We looking forward to speaking with you!